Richard Resnick New York, USA
- Technology futurist
- CEO of Cureatr, a venture-backed technology company revolutionizing the delivery of real-time healthcare
- Expert speaker on genomes and life science
Richard Resnick is currently the CEO of Cureatr, a venture-backed technology company revolutionizing the delivery of real-time healthcare. Prior, he led GQ Life Sciences, a venture-backed software and data company, through a successful turnaround and acquisition in Q4 2016. He was previously CEO of Harmony Line, Inc., an MIT Media Lab company, where he partnered with the famous composer/technologist Tod Machover to develop and commercialize Hyperscore, a unique software tool to enable anyone to compose music. Prior to Harmony Line, Resnick was the CEO of Mosaic Bioinformatics which he sold to NetGenics in 2000. Resnick was the global bioinformatics software head for Wyeth Pharmaceuticals, and got his start in genomics working on the Human Genome Project under Eric Lander at the MIT Whitehead Institute, authoring software applications like primer3, still widely in use some 20 years later.
Resnick frequently gives talks to the public on the implications of cheap genome sequencing and genome editing, the future of healthcare, and entrepreneurial leadership. His book, The Coming Genetic Wars, was published in 2019.
Resnick holds an M.B.A. from the MIT Sloan School of Management, an M.S. in Computer Science from Worcester Polytechnic Institute, and a B.S in Computer Science from the University of Massachusetts at Amherst.
For availability and speaker fees, please contact Richard Resnick’s speaking agent at Chartwell here, or call +1 972 385 1021 for U.S. inquiries or +44 207 293 0864 for international inquiries.